Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Tardif, É. Rhéaume, L. Perreault, J. Grégoire, Yassamin Zada, Géraldine Asselin, S. Provost, A. Barhdadi, D. Rhainds, P. L'Allier, R. Ibrahim, R. Upmanyu, E. Niesor, R. Benghozi, G. Suchánková, F. Laghrissi-Thode, M. Guertin, A. Olsson, I. Mongrain, G. Schwartz, M. Dubé (2015)
Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCirculation: Cardiovascular Genetics, 8
G. Schwartz, A. Olsson, M. Abt, C. Ballantyne, P. Barter, J. Brumm, B. Chaitman, I. Holme, D. Kallend, Lawrence Leiter, E. Leitersdorf, J. McMurray, H. Mundl, S. Nicholls, P. Shah, J. Tardif, R. Wright (2012)
Effects of dalcetrapib in patients with a recent acute coronary syndrome.The New England journal of medicine, 367 22
S. Nissen, S. Pillai, Stephen Nicholls, Stephen Nicholls, K. Wolski, J. Riesmeyer, G. Weerakkody, Wendra Foster, E. McErlean, Lin Li, P. Bhatnagar, G. Ruotolo, A. Lincoff (2018)
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control StudyJAMA Cardiology, 3
M. Lincoff, S. Nicholls, J. Riesmeyer, P. Barter, B. Brewer, K. Fox, M. Gibson, C. Granger, V. Menon, G. Montalescot, D. Rader, A. Tall, E. McErlean, K. Wolski, G. Ruotolo, B. Vangerow, G. Weerakkody, S. Goodman, D. Conde, Darren Mcguire, J. Nicolau, J. Leiva-Pons, Y. Pesant, Weimin Li, D. Kandath, S. Kouz, N. Tahirkheli, D. Mason, S. Nissen (2017)
Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular DiseaseThe New England Journal of Medicine, 376
Tardif (2015)
Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib.Circ Cardiovasc Genet, 8
Rui Xiao, M. Boehnke (2009)
Quantifying and correcting for the winner's curse in genetic association studiesGenetic Epidemiology, 33
Letters 4. JensenMD,RyanDH,ApovianCM,etal;AmericanCollegeofCardiology/American cardiovascular outcomes in patients with a recent acute HeartAssociationTaskForceonPracticeGuidelines;ObesitySociety.2013AHA/ACC/ coronary syndrome and AA genotype at the rs1967309 SNP TOS guideline for the management of overweight and obesity in adults: a report of in the ADCY9 gene. the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25, pt B): 2985-3023. doi:10.1016/j.jacc.2013.11.004 Marc A. Pfeffer, MD, PhD Marie-Pierre Dubé, PhD Randomized Clinical Trial Needed to Confirm Jean-Claude Tardif, MD Whether Dalcetrapib Improves Outcomes Author Affiliations: Cardiovascular Division, Brigham and Women’s Hospital, for Specific ADCY9 Genotype Boston, Massachusetts (Pfeffer); Montreal Heart Institute, Université de To the Editor Nissen et al conducted a nested case-control study Montréal Beaulieu-Saucier, Montreal, Quebec, Canada (Dubé); Montreal Heart from a subgroup of the Assessment of Clinical Effects of Cho- Institute Coordinating Center, Universite de Montréal, Montreal, Quebec, Canada (Tardif). lesteryl Ester Transfer Protein Inhibition with Evacetrapib in Corresponding Author: Marc A. Pfeffer, MD, PhD, Cardiovascular Division, Patients at a High Risk for Vascular Outcomes (ACCELERATE) Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115 trial “to determine whether the association between the SNP (mpfeffer@rics.bwh.harvard.edu). [single-nucleotide polymorphism] in the ADCY9 gene and a
JAMA Cardiology – American Medical Association
Published: Sep 8, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.